Corporate MembershipContact Carol Teal Christner at [email protected] for information about Corporate Membership Privileges
|
||||||||||||||||||||||||||||||||||||
Corporate Partners
Announcements
ASH Submits Comments on IPPS Proposed Rule
On July 9, ASH submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the Inpatient Prospective Payment System (IPPS) proposed rule. ASH’s comments focused on reimbursement for chimeric antigen receptor (CAR) T-cell therapy and the proposed changes to payment for allogeneic hematopoietic stem cell acquisition costs. ASH expressed support for the new proposed MS-DRG for CAR T-cell therapy, which, if finalized, will be the highest weighted MS-DRG. ASH also thanked CMS for the significant steps taken by CMS to help ensure that physicians and institutions are being reimbursed for the care provided. In addition, the Society supported the proposed changes to payment for allogeneic hematopoietic stem cell acquisition costs, a service which has long been under-reimbursed.
Find out more
ASH Submits Comments on Medicaid Proposed Rule on Value-Based Payments
On July 17, ASH submitted a letter to the Centers for Medicare and Medicaid Services (CMS) on a proposed rule aiming to reduce barriers within the Medicaid program to make it easier for payers to implement value-based payment (VBP) arrangements. ASH supports the development of VBP arrangements, especially for innovative therapies, as long as they are evidence-based, clinically appropriate, and patient centric. The rule also included proposals to limit opioid prescriptions in certain situations – ASH urged the agency to exempt individuals with sickle cell disease from these restrictions.
Find out more
ASCO COVID-19 Telehealth Updates, May 8, 2020
Click HERE to view the slide presentation from the webinar.
Open Payments: Review and Dispute Process Open April 1
On April 1, 2020, the review, dispute, and correction process for the Open Payments Program for program year 2019 will open. Physicians and teaching hospitals may review and dispute any updated records attributed to them by reporting entities until May 15.
Find out more